UBS Maintains Buy on Acadia Healthcare Co, Raises Price Target to $102
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Andrew Mok maintains a Buy rating on Acadia Healthcare Co (NASDAQ:ACHC) and raises the price target from $88 to $102.
February 28, 2024 | 6:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Andrew Mok maintains a Buy rating on Acadia Healthcare Co and raises the price target from $88 to $102.
The upgrade in the price target by UBS from $88 to $102 reflects a positive outlook on Acadia Healthcare Co's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100